Cepharanthine attenuates lipopolysaccharide-induced mice mastitis by suppressing the NF-κB signaling pathway

Inflammation

Volumn 37, Issue 2, 2014, Pages 331-337

  Ershun, Zhou ^a   Yunhe, Fu ^a   Zhengkai, Wei ^a   Yongguo, Cao ^a   Naisheng, Zhang ^a   Zhengtao, Yang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

cepharanthine; LPS; mastitis; NF B

Indexed keywords

CEPHARANTHINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; INOCULATION; MALE; MAMMARY GLAND; MASTITIS; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZYLISOQUINOLINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MAMMARY GLANDS, ANIMAL; MASTITIS; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; NF-KAPPA B; PEROXIDASE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896332455     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9744-6     Document Type: Article

References (30)

1. Watts, J.L. 1988. Etiological agents of bovine mastitis. Vet Microbiol 16: 41-66.
2. Viguier, C.; S. Arora, N. Gilmartin, K. Welbeck, and R. O'Kennedy. 2009. Mastitis detection: current trends and future perspectives. Trends Biotechnol 27: 486-493.
3. Elazar, S.; E. Gonen, A. Livneh-Kol, I. Rosenshine, and N.Y. Shpigel. 2010. Essential role of neutrophils but not mammary alveolar macrophages in a murine model of acute Escherichia coli mastitis. Vet Res 41: 53.
4. Kauf, A.C.; B.T. Vinyard, and D.D. Bannerman. 2007. Effect of intramammary infusion of bacterial lipopolysaccharide on experimentally induced Staphylococcus aureus intramammary infection. Res Vet Sci 82: 39-46.
5. Lee, J.W.; M.J. Paape, T.H. Elsasser, and X. Zhao. 2003. Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia coli lipopolysaccharide. J Dairy Sci 86: 2382-2389.
6. Bannerman, D.D.; M.J. Paape, W.R. Hare, and E.J. Sohn. 2003. Increased levels of LPS-binding protein in bovine blood and milk following bacterial lipopolysaccharide challenge. J Dairy Sci 86: 3128-3137.
7. Takeuchi, H.; S. Jin, J. Wang, G. Zhang, J. Kawanokuchi, R. Kuno, Y. Sonobe, T. Mizuno, and A. Suzumura. 2006. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281: 21362-21368.
8. Hartlage-Rubsamen, M.; R. Lemke, and R. Schliebs. 1999. Interleukin-1beta, inducible nitric oxide synthase, and nuclear factor-kappaB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-gamma injection. J Neurosci Res 57: 388-398.
9. Toubiana, M.; M. Gerdol, U. Rosani, A. Pallavicini, P. Venier, and P. Roch. 2013. Toll-like receptors and MyD88 adaptors in Mytilus: complete cds and gene expression levels. Dev Comp Immunol 40: 158-166.
10. Bun, S.S.; M. Laget, A. Chea, H. Bun, E. Ollivier, and R. Elias. 2009. Cytotoxic activity of alkaloids isolated from Stephania rotunda [corrected]. Phytother Res 23: 587-590.
11. Kudo, K.; S. Hagiwara, A. Hasegawa, J. Kusaka, H. Koga, and T. Noguchi. 2011. Cepharanthine exerts anti-inflammatory effects via NF-kappaB inhibition in a LPS-induced rat model of systemic inflammation. J Surg Res 171: 199-204.
12. Satoh, H.; G.S. Firestein, P.B. Billings, J.P. Harris, and E.M. Keithley. 2003. Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol 4: 139-147.
13. Libby, P. 2000. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 86: 3J-8J. discussion 8J-9J.
14. Choi, Y.H.; G.Y. Jin, G.Z. Li, and G.H. Yan. 2011. Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW 264.7 macrophages. Biol Pharm Bull 34: 959-966.
15. Matsuno, T.; K. Orita, K. Edashige, H. Kobuchi, E.F. Sato, B. Inouye, M. Inoue, and K. Utsumi. 1990. Inhibition of active oxygen generation in guinea-pig neutrophils by biscoclaurine alkaloids. Biochem Pharmacol 39: 1255-1259.
16. Okamoto, M.; M. Ono, and M. Baba. 1998. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. AIDS Res Hum Retroviruses 14: 1239-1245.
17. Wu, J.; H. Suzuki, A.A. Akhand, Y.W. Zhou, K. Hossain, and I. Nakashima. 2002. Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells. Cell Signal 14: 509-515.
18. Zheng, J.; A.D. Watson, and D.E. Kerr. 2006. Genome-wide expression analysis of lipopolysaccharide-induced mastitis in a mouse model. Infect Immun 74: 1907-1915.
19. Luo, H.B.R.; and F. Loison. 2008. Constitutive neutrophil apoptosis: mechanisms and regulation. Am J Hematol 83: 288-295.
20. Brouillette, E.; and F. Malouin. 2005. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect 7: 560-568.
21. Demeyere, K.; Q. Remijsen, D. Demon, K. Breyne, S. Notebaert, F. Boyen, C.J. Guerin, P. Vandenabeele, and E. Meyer. 2013. Escherichia coli induces bovine neutrophil cell death independent from caspase-3/-7/-1, but with phosphatidylserine exposure prior to membrane rupture. Vet Immunol Immunopathol 153: 45-56.
22. Skotnicka, B.; and E. Hassmann. 2008. Proinflammatory and immunoregulatory cytokines in the middle ear effusions. Int J Pediatr Otorhinolaryngol 72: 13-17.
23. Giebelen, I.A.; D.J. van Westerloo, G.J. LaRosa, A.F. de Vos, and T. van der Poll. 2007. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28: 700-703.
24. Buraczynska, M.; P. Ksiazek, P. Kubit, and W. Zaluska. 2006. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure. Cytokine 36: 167-172.
25. Jirik, F.R.; T.J. Podor, T. Hirano, T. Kishimoto, D.J. Loskutoff, D.A. Carson, and M. Lotz. 1989. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 142: 144-147.
26. Notebaert, S.; and D. Demon. 2008. Vanden Berghe T, Vandenabeele P, Meyer E: Inflammatory mediators in Escherichia coli-induced mastitis in mice. Comp Immunol Microbiol Infect Dis 31: 551-565.
27. Li, Q.; and I.M. Verma. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
28. Baeuerle, P.A.; and D. Baltimore. 1996. NF-kappa B: ten years after. Cell 87: 13-20.
29. Pahl, H.L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
30. Notebaert, S.; H. Carlsen, D. Janssen, P. Vandenabeele, R. Blomhoff, and E. Meyer. 2008. In vivo imaging of NF-kappaB activity during Escherichia coli-induced mammary gland infection. Cell Microbiol 10: 1249-1258.